Oncology

Treatment used in combination with fluorouracil and leucovorin for patients with metastatic pancreatic cancer.

Program takes advantage of neuroplasticity to train the brain to work more efficiently.

Top news of the week in cancer drug development.

Rare ALK mutation allows patients to live an average of 4 years with the disease controlled.

More than half of patients did not return to physicians for follow-up care.

Women increasingly choosing surgery to remove both breasts.

Research may improve the design of pharmaceuticals for leukemia and other types of cancer.

Breast Cancer and the Environment Research Program will focus on racially and ethnically diverse communities and expand the study of risk factors.

Despite new advanced immunotherapies, surgical resection still is the most effective treatment for abdominal metastatic melanoma.

Existing medications and myxoma virus combination shows promise against glioblastoma.

Process responsible for cancer cell proliferation uncovered.

HDAC inhibitors stop the activation of genes that turn normal cells into cancerous cells.

Gel may eventually eliminate the need for animal testing in medical research.

Test may help clinicians identify the best course of therapy for patients with Diffuse Large B-Cell Lymphoma.

Research may minimize operations for benign disease while maintaining a low morbidity and mortality for surgical resection.

Researchers seek to improve diagnosis, support genetic counseling, and enhance medical management.

Treatment doubles overall survival of patients with recurrent glioblastoma.

Process makes tumors more sensitive to chemotherapy to improve targeted therapy.

Top news of the week in cancer drug development.

Exercise following diagnosis may offer significant protection among cancer survivors.

App could improve cancer diagnostics in low- to middle-income and remote areas.

Study determines which genetic mutations in cancer will be most likely to respond to chemotherapy.

High-dose chemotherapy and autologous stem cell transplantation show promise for patients with light-chain amyloidosis.

Many colon cancer disparities found in patients of different races under 50-years old.

Carcinoid syndrome frequently prevents patients from leading active lives.

Dinaciclib may be able to eliminate metastases without shrinking the primary tumor.

Targeted drug delivery focuses on diseased cells to minimize side effects on normal cells.

Significant decrease found in oral and intestinal microbial diversity during chemotherapy.

Opportunistic infections accounted for nearly one-fourth of all readmissions.

Families of children with cancer face food, housing, and energy insecurity.